BCAX NASDAQ
Bicara Therapeutics Inc. Common Stock
1W: -4.7%
1M: -7.0%
3M: -32.5%
YTD: +6.7%
1Y: +2.0%
$17.48
+0.59 (+3.49%)
Weekly Expected Move ±6.3%
$15
$16
$17
$18
$19
Credit Risk of going bust: lower than 88% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Bicara Therapeutics Inc. Common Stock would be worth roughly what it owes.
Total debt $1.2M against a stock market value of $1.16B.
Distance to default 12.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.2M (short-term plus half of long-term), stock volatility 54.2%; Altman Z'' 11.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Bicara Therapeutics Inc. Common Stock would be worth roughly what it owes.
Total debt $1.2M against a stock market value of $1.16B.
Distance to default 12.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.2M (short-term plus half of long-term), stock volatility 54.2%; Altman Z'' 11.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2026-02-26
Earliest Filing
2026-02-26
Latest Filing
partner: 1
Counterparties (Filed by BCAX)
1 relationshipsCompanies named in BCAX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Goodwin Procter LLP | — | partner | Legal counsel providing opinion on the validity of the shares | 2026-02-26 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-25 | Material Agreement; Exhibits | Agreement | View |
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-07-28 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-10 | Shareholder Vote | View | |
| 2026-05-21 | Other Events; Exhibits | View | |
| 2026-05-11 | Earnings Release; Exhibits | View | |
| 2026-03-30 | Earnings Release; Exhibits | View | |
| 2026-02-26 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Financial S | Agreement | View |
| 2026-02-19 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-08 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-06 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-05-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-11-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-09-16 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR